Thromb Haemost 2005; 94(04): 872-878
DOI: 10.1160/TH05-02-0128
New Technologies and Diagnostic Tools
Schattauer GmbH

Detection of known haemophilia B mutations and carrier testing by microarray

Kaimin Chan
1   University Department of Medicine, Queen Mary Hospital, Hong Kong
,
W. Sasanakul
2   Department of Paediatrics, Ramathibodi Hospital, Bangkok, Thailand
,
Gillian Mellars
3   Department of Haematology, Royal Free Hospital, London, UK
,
Ampaiwan Chuansumrit
2   Department of Paediatrics, Ramathibodi Hospital, Bangkok, Thailand
,
D Perry
4   Department of Haematology, Addenbrooke’s Hospital, Cambridge, UK
,
Christine A Lee
3   Department of Haematology, Royal Free Hospital, London, UK
,
Man-Sim Wong
1   University Department of Medicine, Queen Mary Hospital, Hong Kong
,
Tai-Kwong Chan
1   University Department of Medicine, Queen Mary Hospital, Hong Kong
,
Vivian Chan
1   University Department of Medicine, Queen Mary Hospital, Hong Kong
› Author Affiliations
Grant support:This work is supported by a grant from the Vice Chancellor’s Development Fund, University of Hong Kong.
Further Information

Publication History

Received22 February 2005

Accepted after resubmission18 July 2005

Publication Date:
07 December 2017 (online)

Summary

The molecular basis of haemophilia B is heterogeneous and many mutations of the Factor IX (FIX) gene have been characterised. Using the allele-specific arrayed primer extension (ASAPEX) technology, we have designed a FIX array to simultaneously analyse 69 mutations found in British, Thai and Chinese patients. This technology overcomes the problem of multiple reverse dot-blot analysis and has a 100% accuracy in the detection of both affected subjects and carriers in families with known mutations. In seven unknown mutations from Thailand, the array could detect the specific mutation in five and in the remainders the normal primer at specific spots failed to extend due to a mutation a few nucleotides upstream, thus allowing their identification. Hence this FIX array can detect 53% of the 2891 mutation entries in the FIX database. Each of the microarray slide can be used for three different test samples and would be useful for carrier testing for common mutations and prenatal diagnosis. It is simpler and more cost effective than genome sequencing and would be particularly useful in laboratories with limited technical capabilities.

 
  • References

  • 1 Thompson AR. Structure, function and molecular defects of factor IX. Blood 1986; 67: 565-72.
  • 2 Brownlee GG. Haemophilia B: a review of patient defects, diagnosis with gene probes and prospects for gene therapy. Recent advances in Haematology 1988; 5: 251-64.
  • 3 Green PM, Giannelli F, Sommer SS. et al. The haemophilia B mutation database – version 13, 2004. Available from http://www.kcl.ac.uk/ip/petergreen/intro.html.
  • 4 Peake IR, Lillicrap DP, Boulyjenkov V. et al. Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coagul Fibrinolysis 1993; 4: 313-44.
  • 5 Chan V, Yip B, Tong TMF. et al. Molecular defects in haemophilia B: detection by direct restriction enzyme analysis. Br J Haematol 1991; 79: 63-9.
  • 6 Chan V, Yam I, Yip B. et al. Single nucleotide polymorphisms (SNPs) of the factor IX gene for linkage analysis in the southern Chinese population. Br J Haematol 2000; 111: 540-3.
  • 7 Schena M, Shalon D, Davis RW. et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-70.
  • 8 Chan K, Wong MS, Chan TK. et al. A thalassaemia array for Southeast Asia. Br J Haematol 2004; 124: 232-9.
  • 9 Sambrooke J, Fritsch ET, Maniatis T. In: Molecular cloning: a laboratory manual.. New York: Cold Spring Harbour; 1989
  • 10 Zhao X, Nampalli S, Serino AJ. et al. Immobilization of oligodeoxyribonucleotides with multiple anchors to microchips. Nucleic Acids Res 2001; 29: 955-9.
  • 11 Chehab FF. Molecular diagnostics: past, present and future. Hum Mut 1993; 2: 331-7.